SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced that revenues for the second quarter of fiscal year 2009 are expected to range between $20.5 million to $20.8 million. This represents an increase of 43% to 45% compared with the second quarter of fiscal year 2008 and an increase of 12% to 13% compared with the first quarter of fiscal 2009.
